| abstract |
In one aspect, the invention relates to a compound having the formula: wherein R1-R6, a, b, Z and X are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have enkephalinase inhibitory activity. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; to methods of using such compounds; and to methods and intermediates for the preparation of such compounds. |